Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 405.23 Million USD | 9.99% |
| 2023 | 368.44 Million USD | 99.81% |
| 2022 | 184.39 Million USD | 30.88% |
| 2021 | 140.88 Million USD | 9.42% |
| 2020 | 128.75 Million USD | 3.98% |
| 2019 | 123.82 Million USD | 3.14% |
| 2018 | 120.05 Million USD | 12.18% |
| 2017 | 107.02 Million USD | 10.7% |
| 2016 | 96.67 Million USD | 11.68% |
| 2015 | 86.56 Million USD | 9.29% |
| 2014 | 79.2 Million USD | 15.15% |
| 2013 | 68.78 Million USD | 17.21% |
| 2012 | 58.68 Million USD | 12.95% |
| 2011 | 51.95 Million USD | 12.71% |
| 2010 | 46.09 Million USD | 18.36% |
| 2009 | 38.94 Million USD | 10.6% |
| 2008 | 35.21 Million USD | 13.38% |
| 2007 | 31.05 Million USD | 24.43% |
| 2006 | 24.96 Million USD | 14.32% |
| 2005 | 21.83 Million USD | 9.35% |
| 2004 | 19.96 Million USD | 11.3% |
| 2003 | 17.94 Million USD | 16.49% |
| 2002 | 15.4 Million USD | 14.31% |
| 2001 | 13.47 Million USD | 19.92% |
| 2000 | 11.23 Million USD | 2.14% |
| 1999 | 11 Million USD | 13.4% |
| 1998 | 9.7 Million USD | 16.87% |
| 1997 | 8.3 Million USD | 18.57% |
| 1996 | 7 Million USD | 9.38% |
| 1995 | 6.4 Million USD | 16.36% |
| 1994 | 5.5 Million USD | 14.58% |
| 1993 | 4.8 Million USD | 14.29% |
| 1992 | 4.2 Million USD | 2.44% |
| 1991 | 4.1 Million USD | 5.13% |
| 1990 | 3.9 Million USD | 14.71% |
| 1989 | 3.4 Million USD | 17.24% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 104.86 Million USD | 2.49% |
| 2024 Q2 | 102.3 Million USD | 4.8% |
| 2024 Q4 | 95.91 Million USD | -8.54% |
| 2024 Q1 | 97.62 Million USD | -2.14% |
| 2024 FY | 385.2 Million USD | 4.55% |
| 2023 Q1 | 56.2 Million USD | 19.66% |
| 2023 Q2 | 120.19 Million USD | 113.84% |
| 2023 FY | 368.44 Million USD | 99.81% |
| 2023 Q3 | 92.28 Million USD | -23.22% |
| 2023 Q4 | 99.75 Million USD | 8.1% |
| 2022 Q3 | 51.03 Million USD | 6.05% |
| 2022 Q1 | 38.26 Million USD | 2.21% |
| 2022 Q4 | 46.97 Million USD | -7.96% |
| 2022 FY | 184.39 Million USD | 30.88% |
| 2022 Q2 | 48.12 Million USD | 25.77% |
| 2021 Q3 | 38.07 Million USD | 12.09% |
| 2021 FY | 140.88 Million USD | 9.42% |
| 2021 Q4 | 37.43 Million USD | -1.68% |
| 2021 Q2 | 33.96 Million USD | 8.16% |
| 2021 Q1 | 31.4 Million USD | -1.19% |
| 2020 Q4 | 31.78 Million USD | -1.55% |
| 2020 FY | 128.75 Million USD | 3.98% |
| 2020 Q1 | 31.93 Million USD | 0.41% |
| 2020 Q2 | 32.75 Million USD | 2.58% |
| 2020 Q3 | 32.28 Million USD | -1.43% |
| 2019 Q2 | 31.78 Million USD | 5.08% |
| 2019 Q1 | 30.25 Million USD | 1.75% |
| 2019 Q4 | 31.8 Million USD | 6.04% |
| 2019 Q3 | 29.98 Million USD | -5.66% |
| 2019 FY | 123.82 Million USD | 3.14% |
| 2018 Q1 | 29.44 Million USD | 5.1% |
| 2018 Q4 | 29.73 Million USD | 0.41% |
| 2018 Q3 | 29.6 Million USD | -5.32% |
| 2018 Q2 | 31.27 Million USD | 6.2% |
| 2018 FY | 120.05 Million USD | 12.18% |
| 2017 Q2 | 26.73 Million USD | 3.89% |
| 2017 FY | 107.02 Million USD | 10.7% |
| 2017 Q3 | 26.52 Million USD | -0.79% |
| 2017 Q4 | 28.01 Million USD | 5.61% |
| 2017 Q1 | 25.73 Million USD | -1.87% |
| 2016 FY | 96.67 Million USD | 11.68% |
| 2016 Q4 | 26.22 Million USD | 9.54% |
| 2016 Q1 | 22.89 Million USD | -0.78% |
| 2016 Q2 | 23.61 Million USD | 3.12% |
| 2016 Q3 | 23.94 Million USD | 1.4% |
| 2015 FY | 86.56 Million USD | 9.29% |
| 2015 Q4 | 23.07 Million USD | 7.12% |
| 2015 Q2 | 21.31 Million USD | 3.27% |
| 2015 Q3 | 21.54 Million USD | 1.09% |
| 2015 Q1 | 20.63 Million USD | -1.95% |
| 2014 Q3 | 20.41 Million USD | 3.08% |
| 2014 FY | 79.2 Million USD | 15.15% |
| 2014 Q1 | 17.94 Million USD | -1.1% |
| 2014 Q2 | 19.8 Million USD | 10.34% |
| 2014 Q4 | 21.04 Million USD | 3.11% |
| 2013 Q2 | 16.82 Million USD | 4.1% |
| 2013 Q4 | 18.14 Million USD | 2.82% |
| 2013 FY | 68.78 Million USD | 17.21% |
| 2013 Q1 | 16.16 Million USD | 6.34% |
| 2013 Q3 | 17.64 Million USD | 4.86% |
| 2012 Q2 | 14.51 Million USD | 6.51% |
| 2012 FY | 58.68 Million USD | 12.95% |
| 2012 Q4 | 15.2 Million USD | -0.92% |
| 2012 Q3 | 15.34 Million USD | 5.71% |
| 2012 Q1 | 13.62 Million USD | 1.66% |
| 2011 Q1 | 13.17 Million USD | 3.19% |
| 2011 Q2 | 12.85 Million USD | -2.37% |
| 2011 Q3 | 12.52 Million USD | -2.61% |
| 2011 Q4 | 13.4 Million USD | 7.04% |
| 2011 FY | 51.95 Million USD | 12.71% |
| 2010 Q4 | 12.76 Million USD | 8.98% |
| 2010 Q1 | 10.32 Million USD | 2.5% |
| 2010 Q2 | 11.29 Million USD | 9.37% |
| 2010 Q3 | 11.71 Million USD | 3.7% |
| 2010 FY | 46.09 Million USD | 18.36% |
| 2009 Q1 | 9.15 Million USD | -2.74% |
| 2009 FY | 38.94 Million USD | 10.6% |
| 2009 Q2 | 10.26 Million USD | 12.16% |
| 2009 Q3 | 9.45 Million USD | -7.87% |
| 2009 Q4 | 10.07 Million USD | 6.54% |
| 2008 Q3 | 8.68 Million USD | -7.37% |
| 2008 Q4 | 9.4 Million USD | 8.37% |
| 2008 FY | 35.21 Million USD | 13.38% |
| 2008 Q1 | 7.75 Million USD | -7.47% |
| 2008 Q2 | 9.37 Million USD | 20.94% |
| 2007 FY | 31.05 Million USD | 24.43% |
| 2007 Q4 | 8.37 Million USD | 5.65% |
| 2007 Q3 | 7.92 Million USD | -1.05% |
| 2007 Q2 | 8.01 Million USD | 18.84% |
| 2007 Q1 | 6.74 Million USD | -3.93% |
| 2006 Q1 | 5.73 Million USD | -2.2% |
| 2006 Q2 | 6.14 Million USD | 7.1% |
| 2006 Q3 | 6.06 Million USD | -1.29% |
| 2006 Q4 | 7.01 Million USD | 15.73% |
| 2006 FY | 24.96 Million USD | 14.32% |
| 2005 Q4 | 5.86 Million USD | 13.2% |
| 2005 Q3 | 5.18 Million USD | -9.31% |
| 2005 Q2 | 5.71 Million USD | 12.57% |
| 2005 Q1 | 5.07 Million USD | -10.92% |
| 2005 FY | 21.83 Million USD | 9.35% |
| 2004 Q1 | 4.38 Million USD | -5.96% |
| 2004 FY | 19.96 Million USD | 11.3% |
| 2004 Q4 | 5.69 Million USD | 10.39% |
| 2004 Q3 | 5.16 Million USD | 9.27% |
| 2004 Q2 | 4.72 Million USD | 7.68% |
| 2003 Q1 | 4.27 Million USD | 0.54% |
| 2003 Q2 | 4.67 Million USD | 9.21% |
| 2003 Q3 | 4.32 Million USD | -7.41% |
| 2003 Q4 | 4.66 Million USD | 7.81% |
| 2003 FY | 17.94 Million USD | 16.49% |
| 2002 Q1 | 3.65 Million USD | 5.09% |
| 2002 Q3 | 3.5 Million USD | -11.81% |
| 2002 Q4 | 4.25 Million USD | 21.26% |
| 2002 Q2 | 3.97 Million USD | 8.81% |
| 2002 FY | 15.4 Million USD | 14.31% |
| 2001 Q1 | 3.19 Million USD | 21.86% |
| 2001 Q2 | 3.38 Million USD | 5.95% |
| 2001 Q3 | 3.41 Million USD | 0.92% |
| 2001 Q4 | 3.48 Million USD | 1.9% |
| 2001 FY | 13.47 Million USD | 19.92% |
| 2000 Q1 | 2.6 Million USD | -3.7% |
| 2000 FY | 11.23 Million USD | 2.14% |
| 2000 Q4 | 2.62 Million USD | -15.42% |
| 2000 Q3 | 3.09 Million USD | 6.86% |
| 2000 Q2 | 2.9 Million USD | 11.54% |
| 1999 Q3 | 2.6 Million USD | -3.7% |
| 1999 FY | 11 Million USD | 13.4% |
| 1999 Q1 | 3 Million USD | 11.11% |
| 1999 Q2 | 2.7 Million USD | -10.0% |
| 1999 Q4 | 2.7 Million USD | 3.85% |
| 1998 Q3 | 2.3 Million USD | -8.0% |
| 1998 Q4 | 2.7 Million USD | 17.39% |
| 1998 FY | 9.7 Million USD | 16.87% |
| 1998 Q2 | 2.5 Million USD | 8.7% |
| 1998 Q1 | 2.3 Million USD | 9.52% |
| 1997 Q2 | 2.1 Million USD | 0.0% |
| 1997 FY | 8.3 Million USD | 18.57% |
| 1997 Q4 | 2.1 Million USD | 10.53% |
| 1997 Q1 | 2.1 Million USD | 16.67% |
| 1997 Q3 | 1.9 Million USD | -9.52% |
| 1996 Q4 | 1.8 Million USD | 5.88% |
| 1996 FY | 7 Million USD | 9.38% |
| 1996 Q3 | 1.7 Million USD | -10.53% |
| 1996 Q2 | 1.9 Million USD | 5.56% |
| 1996 Q1 | 1.8 Million USD | 116.22% |
| 1995 Q1 | - USD | 100.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 FY | 6.4 Million USD | 16.36% |
| 1995 Q4 | -11.1 Million USD | 0.0% |
| 1994 FY | 5.5 Million USD | 14.58% |
| 1994 Q2 | 1.5 Million USD | 25.0% |
| 1994 Q3 | - USD | -100.0% |
| 1994 Q4 | -9.8 Million USD | 0.0% |
| 1994 Q1 | 1.2 Million USD | 114.46% |
| 1993 FY | 4.8 Million USD | 14.29% |
| 1993 Q4 | -8.3 Million USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | -100.0% |
| 1993 Q1 | 1.1 Million USD | 114.47% |
| 1992 Q4 | -7.6 Million USD | 0.0% |
| 1992 FY | 4.2 Million USD | 2.44% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 100.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | 4.1 Million USD | 5.13% |
| 1991 Q4 | -7.2 Million USD | 0.0% |
| 1991 Q1 | - USD | 100.0% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | -7 Million USD | 0.0% |
| 1990 FY | 3.9 Million USD | 14.71% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | 3.4 Million USD | 17.24% |
| 1989 Q4 | -6.4 Million USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | -171.984% |
| Prenetics Global Limited | 60.73 Million USD | -567.204% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -2390.395% |
| CareDx, Inc | 277.76 Million USD | -45.89% |
| Exact Sciences Corporation | 2.06 Billion USD | 80.333% |
| Exagen Inc. | 52.29 Million USD | -674.935% |
| Inotiv, Inc. | 246.9 Million USD | -64.128% |
| Guardant Health, Inc. | 901.62 Million USD | 55.055% |
| Biodesix, Inc. | 77.41 Million USD | -423.434% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -10229.547% |
| Precipio, Inc. | 13.63 Million USD | -2871.381% |
| iSpecimen Inc. | 16.27 Million USD | -2389.589% |
| Natera, Inc. | 938.98 Million USD | 56.843% |
| Aspira Women's Health Inc. | 24.11 Million USD | -1580.505% |
| Standard BioTools Inc. | 113.48 Million USD | -257.072% |
| 23andMe Holding Co. | 420.73 Million USD | 3.683% |
| Castle Biosciences, Inc. | 242.78 Million USD | -66.913% |
| Personalis, Inc. | 128.14 Million USD | -216.236% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | -266.647% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -2357.96% |
| OpGen, Inc. | 30.65 Million USD | -1221.8% |
| T2 Biosystems, Inc. | 41.49 Million USD | -876.616% |
| Myriad Genetics, Inc. | 600.1 Million USD | 32.472% |
| ICON Public Limited Company | 755.64 Million USD | 46.372% |
| NeoGenomics, Inc. | 341.25 Million USD | -18.75% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -2390.395% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 62.919% |
| RadNet, Inc. | 268.87 Million USD | -50.714% |
| MDxHealth SA | 71.25 Million USD | -468.706% |
| Psychemedics Corporation | 11.33 Million USD | -3475.41% |
| Illumina, Inc. | 3.81 Billion USD | 89.372% |
| Check-Cap Ltd. | 19.28 Million USD | -2001.089% |
| Twist Bioscience Corporation | 354.18 Million USD | -14.416% |
| DarioHealth Corp. | 62.17 Million USD | -551.789% |
| Fulgent Genetics, Inc. | 171.9 Million USD | -135.732% |
| Sera Prognostics, Inc. | 39.91 Million USD | -915.199% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -3751.794% |
| OPKO Health, Inc. | 574.68 Million USD | 29.485% |
| Medpace Holdings, Inc. | 187.68 Million USD | -115.919% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -3360.961% |
| Prenetics Global Limited | 60.73 Million USD | -567.204% |
| Mainz Biomed B.V. | 27.15 Million USD | -1392.347% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -4523.437% |
| Trinity Biotech plc | 46.49 Million USD | -771.571% |
| Neuronetics, Inc. | 82.25 Million USD | -392.635% |
| Sotera Health Company | 300.46 Million USD | -34.87% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -4523.437% |